Published in Obstet Gynecol on March 01, 2004
Willingness to pay for genetic testing for Alzheimer's disease: a measure of personal utility. Genet Test Mol Biomarkers (2011) 1.06
Measuring the effects of unintended pregnancy on women's quality of life. Contraception (2008) 0.99
The changing landscape for the elimination of racial/ethnic health status disparities. J Health Care Poor Underserved (2004) 0.83
Risk and the pregnant body. Hastings Cent Rep (2009) 4.63
Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Ann Intern Med (2011) 3.52
Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational Study. Arch Intern Med (2011) 3.00
Cost utility of prenatal diagnosis and the risk-based threshold. Lancet (2004) 3.00
Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. N Engl J Med (2003) 2.72
A randomized comparison of total or supracervical hysterectomy: surgical complications and clinical outcomes. Obstet Gynecol (2003) 2.57
Racial/ethnic disparities in obstetric outcomes and care: prevalence and determinants. Am J Obstet Gynecol (2010) 2.37
Risks, values, and decision making surrounding pregnancy. Obstet Gynecol (2007) 2.11
Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning: the medicine or surgery (Ms) randomized trial. JAMA (2004) 1.97
Perinatal outcomes in low-risk term pregnancies: do they differ by week of gestation? Am J Obstet Gynecol (2008) 1.95
Induction of labor and cesarean delivery by gestational age. Am J Obstet Gynecol (2006) 1.62
Maternal ethnicity, paternal ethnicity, and parental ethnic discordance: predictors of preeclampsia. Obstet Gynecol (2005) 1.60
Mode of delivery: toward responsible inclusion of patient preferences. Obstet Gynecol (2008) 1.57
Hysterectomy versus expanded medical treatment for abnormal uterine bleeding: clinical outcomes in the medicine or surgery trial. Obstet Gynecol (2004) 1.52
Recruitment strategies for minority participation: challenges and cost lessons from the POWER interview. Ethn Dis (2005) 1.52
Day-to-Day Impact of Vaginal Aging questionnaire: a multidimensional measure of the impact of vaginal symptoms on functioning and well-being in postmenopausal women. Menopause (2015) 1.47
Decrease in urinary incontinence management costs in women enrolled in a clinical trial of weight loss to treat urinary incontinence. Obstet Gynecol (2012) 1.45
A community-based study of acne-related health preferences in adolescents. Arch Dermatol (2008) 1.44
Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction. Cancer (2005) 1.43
Randomized controlled trial of a breath-actuated nebulizer in pediatric asthma patients in the emergency department. Respir Care (2011) 1.41
Evidence into policy and practice? Measuring the progress of U.S. and U.K. policies to tackle disparities and inequalities in U.S. and U.K. health and health care. Milbank Q (2006) 1.39
Beyond race or ethnicity and socioeconomic status: predictors of prenatal testing for Down syndrome. Obstet Gynecol (2006) 1.36
Neonatal complications of term pregnancy: rates by gestational age increase in a continuous, not threshold, fashion. Am J Obstet Gynecol (2005) 1.35
Maternal and obstetric complications of pregnancy are associated with increasing gestational age at term. Am J Obstet Gynecol (2007) 1.35
Racial and ethnic disparities in benign gynecologic conditions and associated surgeries. Am J Obstet Gynecol (2010) 1.32
Computerized prenatal genetic testing decision-assisting tool: a randomized controlled trial. Obstet Gynecol (2009) 1.18
Health care report cards: implications for vulnerable patient groups and the organizations providing them care. J Health Polit Policy Law (2002) 1.16
Who is at risk for prolonged and postterm pregnancy? Am J Obstet Gynecol (2009) 1.15
Sexual function and aging in racially and ethnically diverse women. J Am Geriatr Soc (2009) 1.11
Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests. Obstet Gynecol (2006) 1.09
Quality and equality in obstetric care: racial and ethnic differences in caesarean section delivery rates. Paediatr Perinat Epidemiol (2009) 1.08
"I'm going to die of something anyway": women's perceptions of tamoxifen for breast cancer risk reduction. Ethn Dis (2005) 1.04
What parents want to know about the storage and use of residual newborn bloodspots. Am J Med Genet A (2014) 1.04
Time of delivery and neonatal morbidity and mortality. Am J Obstet Gynecol (2008) 1.04
Maternal and paternal race/ethnicity are both associated with gestational diabetes. Am J Obstet Gynecol (2010) 1.01
Prepregnancy body mass index and the length of gestation at term. Am J Obstet Gynecol (2007) 1.00
Effect of noncancerous pelvic problems on health-related quality of life and sexual functioning. Obstet Gynecol (2007) 1.00
Obstetricians' attitudes and beliefs regarding umbilical cord clamping. J Matern Fetal Neonatal Med (2013) 0.97
Social and familial context of prenatal genetic testing decisions: are there racial/ethnic differences? Am J Med Genet C Semin Med Genet (2003) 0.94
Smoking cessation counseling with young patients: the practices of family physicians and pediatricians. Arch Pediatr Adolesc Med (2004) 0.93
Patient preferences for different severities of and treatments for overactive bladder. Female Pelvic Med Reconstr Surg (2011) 0.93
Medicine or Surgery (Ms): a randomized clinical trial comparing hysterectomy and medical treatment in premenopausal women with abnormal uterine bleeding. Control Clin Trials (2004) 0.92
Finding autonomy in birth. Bioethics (2009) 0.91
The Association of Expanded Access to a Collaborative Midwifery and Laborist Model With Cesarean Delivery Rates. Obstet Gynecol (2015) 0.90
Effects of changes in prenatal aneuploidy screening policies in an integrated health care system. Obstet Gynecol (2013) 0.90
First- vs second-trimester ultrasound: the effect on pregnancy dating and perinatal outcomes. Am J Obstet Gynecol (2008) 0.90
Impact of Weight Extremes on Clinical Outcomes in Pediatric Acute Respiratory Distress Syndrome. Crit Care Med (2016) 0.90
Management of the low-grade abnormal Pap smear: What are women's preferences? J Fam Pract (2002) 0.90
Sexual functioning after total compared with supracervical hysterectomy: a randomized trial. Obstet Gynecol (2005) 0.89
Development and validation of a sexual functioning measure for use in diverse women's health outcome studies. Am J Obstet Gynecol (2008) 0.89
Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness. Obstet Gynecol (2010) 0.89
Perceived risk of prenatal diagnostic procedure-related miscarriage and Down syndrome among pregnant women. Am J Obstet Gynecol (2008) 0.89
Predictors of hysterectomy use and satisfaction. Obstet Gynecol (2010) 0.89
How do women of diverse backgrounds value prenatal testing outcomes? Prenat Diagn (2004) 0.88
Using visual displays to communicate risk of cancer to women from diverse race/ethnic backgrounds. Patient Educ Couns (2012) 0.87
Influence of patient preferences on the cost-effectiveness of screening for lynch syndrome. J Oncol Pract (2012) 0.87
Ending cervical cancer screening: attitudes and beliefs from ethnically diverse older women. Am J Obstet Gynecol (2008) 0.86
Understanding risk, patient and provider preferences, and obstetrical decision making: approach to delivery after cesarean. Semin Perinatol (2010) 0.86
Decision making for primary cesarean delivery: the role of patient and provider preferences. Semin Perinatol (2012) 0.85
Comparison and correlates of three preference-based health-related quality-of-life measures among overweight and obese women with urinary incontinence. Qual Life Res (2011) 0.85
Factors associated with undergoing bilateral salpingo-oophorectomy at the time of hysterectomy for benign conditions. Obstet Gynecol (2009) 0.84
Abortion attitudes of pregnant women in prenatal care. Am J Obstet Gynecol (2005) 0.84
Identifying a "range of reasonable options" for cervical cancer screening. Obstet Gynecol (2015) 0.83
Conservative versus aggressive follow up of mildly abnormal Pap smears: testing for process utility. Health Econ (2003) 0.83
Randomized trial of medical treatment versus hysterectomy for abnormal uterine bleeding: resource use in the Medicine or Surgery (Ms) trial. Am J Obstet Gynecol (2006) 0.83
Long-Term Outcomes of the Total or Supracervical Hysterectomy (TOSH) Trial. Female Pelvic Med Reconstr Surg (2010) 0.82
Nuchal translucency and first trimester biochemical markers for down syndrome screening: a cost-effectiveness analysis. Am J Obstet Gynecol (2002) 0.82
Variation in Women's Understanding of Prenatal Testing. Obstet Gynecol (2015) 0.82
Prevalence and use of complementary health approaches among women with chronic pelvic pain in a prospective cohort study. Pain Med (2014) 0.81
The day-to-day impact of urogenital aging: perspectives from racially/ethnically diverse women. J Gen Intern Med (2009) 0.81
Association between vaginal birth after cesarean delivery and primary cesarean delivery rates. Obstet Gynecol (2013) 0.81
Preferences for genetic testing to identify hereditary colorectal cancer: perspectives of high-risk patients, community members, and clinicians. J Cancer Educ (2012) 0.81
Race/Ethnicity and pregnancy decision making: the role of fatalism and subjective social standing. J Womens Health (Larchmt) (2010) 0.81
Attitudes toward birth spacing among low-income, postpartum women: a qualitative analysis. Matern Child Health J (2012) 0.80
Predictors of postpartum sexual activity and function in a diverse population of women. J Midwifery Womens Health (2013) 0.80
Oophorectomy in premenopausal women: health-related quality of life and sexual functioning. Obstet Gynecol (2007) 0.80
Chemoprevention: drug pricing and mortality: the case of tamoxifen. Cancer (2006) 0.79
Tamoxifen for breast cancer risk reduction: impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysis. Med Care (2008) 0.79
Predictors of hysterectomy in women with common pelvic problems: a uterine survival analysis. J Am Coll Surg (2007) 0.79
Predictors of impact of vaginal symptoms in postmenopausal women. Menopause (2016) 0.78
Contributions of hysterectomy and uterus-preserving surgery to health-related quality of life. Obstet Gynecol (2013) 0.78
Influence of patient preferences on the cost-effectiveness of screening for Lynch syndrome. Am J Manag Care (2012) 0.78
Perceptions of prenatal testing for birth defects among rural Latinas. Matern Child Health J (2007) 0.78
Symptom resolution after hysterectomy and alternative treatments for chronic pelvic pain: does depression make a difference? Am J Obstet Gynecol (2011) 0.78
Prevalence and incidence of urinary incontinence in a diverse population of women with noncancerous gynecologic conditions. Female Pelvic Med Reconstr Surg (2010) 0.78
Recurrence of Preterm Birth and Early Term Birth. Obstet Gynecol (2016) 0.78
Patient willingness to participate in a clinical trial with preimplantation genetic diagnosis. Fertil Steril (2007) 0.77
Prenatal Testing in the Genomic Age: Clinical Outcomes, Quality of Life, and Costs. Obstet Gynecol (2015) 0.77
The effect of weight loss on changes in health-related quality of life among overweight and obese women with urinary incontinence. Qual Life Res (2011) 0.76